Citations

Clear

2504 citation(s) found for "Wu, Benjamin".

Bioorthogonal “Click Chemistry” Bone Cement Enables Pro-Translational Spinal Fusion in a Large Animal Sheep Model
Liu, Xifeng , Dashtdar, Babak , Hamouda, Abdelrahman M., Brown, Robert A., Li, Wenkai , Potes, Maria Astudillo , Miller, A. Lee , Li, Hailong, Schreiber, Areonna , Gasvoda, Kaelyn L. , Elder, Benjamin D., Lu, Lichun , Astudillo Potes, Maria D, Miller, Alan Lee , Shafi, Mahnoor , Schreiber, Areonna C , Lu, Lichun , Rezaei, Asghar , Hamouda, Abdelrahman M., Elder, Benjamin D.

Mayo Clinic

ACS Biomaterials Science & Engineering | May 4, 2026 | Volume: 12 | Issue: 6 | Pages: 3054-3068

10.1021/acsbiomaterials.6c00348 | PMID 42080332 Get It

Unraveling B Cell Lymphoma Presenting as AKI and Hypercalcemia in a Patient with BACH2 Variant and CVID
Wonnaparhown, Alex , Wright, Benjamin, Crawford, Renee, Wright, Benjamin

Mayo Clinic

Journal of Human Immunity | May 1, 2026 | Volume: 2 | Issue: CIS2026 | Pages: No page available

10.70962/cis2026abstract.110 Get It

Introduction BACH2-related immunodeficiency and autoimmunity (BRIDA) increases the risk of developing B cell lymphoma. We present a case of a patient with a known history of common variable immunodeficiency (CVID) and BACH2 variant of uncertain significance, presenting with hypercalcemia and acute kidney injury (AKI), found to have T cell histiocyte-rich large B cell lymphoma of the spleen. Case Description 46-year-old male with CVID-like clinical picture with variant of uncertain significance in BACH2 (Combined Annotation Dependent Depletion [CADD] 25.2, allele frequency 2) and granulomatous-lymphocytic interstitial lung disease (GL-ILD), admitted for acute kidney injury with hypercalcemia. He is pancytopenic, hypercalcemic, with marked splenomegaly on CT. PET-CT showed retroperitoneal and iliac chain lymphadenopathy along with mixed changes of osseous/marrow lesions with new lesions in the thoracic spine and left mid femur. There is a notable improvement in GL-ILD on CT chest while the patient is on prednisone. Renal biopsy showed acute tubular injury with increased deposition of calcium phosphate, along with moderate interstitial fibrosis and tubular atrophy with mild fibrointimal thickening of arteries. No monoclonal protein detected in the serum, negative JC virus, BK virus, EBV, CMV, and HIV. Splenic biopsy showed B cell lymphoma with features of micronodular T cell/histiocyte-rich large B cell lymphoma of the spleen. Patient initiated on rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone treatment protocol. Discussion BACH2 is a regulator of T and B cell differentiation and maturation. The effect of BACH2 on T cells involves limiting the differentiation of regulatory T (Treg) cells, which aid in preventing autoimmunity. BACH2 mutations have been described in the literature in patients with CVID and autoimmunity, such as ulcerative colitis. Lymphoma can cause hypercalcemia, which can lead to acute kidney injury. This patient has a variant of uncertain significance in BACH2 with CADD 25.2, allele frequency 2. His clinical picture of CVID, acute kidney injury in the setting of hypercalcemia, and newfound B cell lymphoma of the spleen may be due to this variant of uncertain significance. Further studies need to be conducted to better understand this gene and its role in CVID and B cell lymphoma. Tabular data are included as downloadable supplement files.
Predictors and impact of multiple listing for liver transplantation in the United States across the acuity circles eras
Cywes, Claire , Bankes, Audrey C , Hamandi, Ali, Daniels, Robert J, Fipps, David C. , Lee, Frank G, Ellertson, Marka F, Limburg, Benjamin , Beaman, Lindsay R. , Diwan, Tayyab S, Ellertson, Marka , Hamandi, Ali M, Ellertson, Marka F. , Fipps, David C , Beaman, Lindsay , Bankes, Audrey , Lee, Frank G , Diwan, Tayyab S.

Mayo Clinic

Liver Transplantation | April 28, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/lvt.0000000000000892 | PMID 42048126 Get It

Multi-listing (ML) increases the odds of transplantation compared with single-center listing. However, not all patients have equivalent access to ML. The recent allocation policy change prioritized distance from the donor hospital in an attempt to decrease geographic disparities. This study assessed access to liver transplant (LT) given ML practices before and after the acuity circles policy change. United Network for Organ Sharing data were queried for LTs between January 1, 2016, and November 1, 2024. Patients were grouped by listing at one versus multiple centers and by acuity circle era (ACE). Cohort characteristics and comparisons were described using chi-square and Wilcoxon rank tests. Multivariable logistic regressions and propensity score match (PSM) were performed to assess associations between ML and LT. The final cohort consisted of 105,030 patients; 4084 (3.9%) were multi-listed. Racial/ethnic minority groups, less educated, and publicly insured candidates were less often multi-listed. ML was positively associated with LT in all analyses (overall: OR=1.180, p <0.001; PSM: OR=1.164, p =0.001; pre-ACE: OR=1.127, p =0.015; post-ACE: OR=1.218, p <0.001). Education, race/ethnicity, and insurance type were also associated with LT across all analyses. ML patients were more often transplanted at their primary center with a significant increase in primary center LT post-ACE (53.4% vs. 63.4%, p <0.001). ML and LT had a positive correlation. There was a negative association between minority groups and ML as well as LT. Although acuity circles decreased geographic disparities, they did not change ML accessibility across candidates.
Widening participation in the International League Against Epilepsy: Looking to the future
Cross, J. Helen , Coleman, Lauren, Oritz, Sebastian, Ivaniuk, Alina, Nome, Cecilie G. , Roza, Eugenia, Shafer, Patricia O. , Gaudecker, Jane von, Ryan, Chris, Brinkmann, Benjamin H. , Neuray, Caroline , Welty, Tim, Wiebe, Samuel , Guekht, Alla, Shafer, Patricia Osborne , Brinkmann, Benjamin H , Cross, Helen J , Ivaniuk, Alina , Roza, Eugenia , Gaudecker, Jane R. von , Wiebe, Samuel , Guekht, Alla B.

Mayo Clinic

Epilepsia Open | April 28, 2026 | Volume: 11 | Issue: 3 | Pages: 719-726

10.1002/epi4.70272 | PMID 42047531 Get It

Abstract The International League Against Epilepsy (ILAE) is a global organization dedicated to improving the lives of people with epilepsy through education, research, and advocacy. Recognizing the need for broader engagement and multidisciplinary collaboration, the ILAE has established five sections: Young Epilepsy Section (YES), Nursing, Social Work and Social Services (SWSSS), Neurotechnology, and Pharmacy. These sections aim to strengthen professional networks, enhance education, and promote innovation in epilepsy care. YES fosters leadership and participation among early‐career professionals, whereas the Nursing Section addresses gaps in epilepsy‐specific training and competency development. SWSSS emphasizes psychosocial care, advocacy, and health equity, supporting Intersectoral Global Action Plan (IGAP) objectives through culturally sensitive interventions. The Neurotechnology section advances the integration and development of innovative tools for diagnosis and treatment, and the Pharmacy section focuses on optimizing medication management and access to antiseizure medications globally. Collectively, these sections contribute to the WHO IGAP by improving policy, care delivery, research, and public health responses. Looking ahead, ILAE seeks to expand multidisciplinary participation, encourage cross‐sectional collaboration, and maintain its role as a leading force in global epilepsy care. Through these initiatives, ILAE continues to build capacity, foster inclusivity, and drive progress toward equitable, comprehensive epilepsy services worldwide. Plain Language Summary The International League Against Epilepsy (ILAE) is the global organization responsible for all healthcare professionals involved in the care of those with epilepsy. Recognizing the increasing number of different disciplines now contributing to epilepsy care, and the need to develop professionals of the future, the ILAE has recognized “sections” of like‐minded individuals to encourage networking and communication. Together, these sections contribute to the WHO Intersectoral Global Action Plan (IGAP) by improving policy, care delivery, research, and public health responses. Moving forward, the ILAE seeks to expand multidisciplinary participation, encourage collaboration, and maintain its role as a leading force in global epilepsy care.
Clinical-grade cryopreservation unlocks transplant-ready human pancreatic and stem cell–derived islets for diabetes therapy
Guo, Zongqi, Khashim, Zenith , Knofczynski, Kyle, Tobolt, Diane, Shivakumar, Sharath Belame, Rangarajan, Parthasarathy , Herman, Adam , Abdulla, Muhamad, Tran, Anna , Fisher, Benjamin , Salomon, Tiana, Lewis-Brinkman, Sean , Steinhoff, Magie, Balamurugan, Appakalai N. , Hering, Bernhard J. , Bischof, John, Finger, Erik B. , Rao, Joseph Sushil , Knofczynski, Kyle R , Fisher, Benjamin J., Etheridge, Michael L. , Ramachandran, Sabarinathan , Peterson, Quinn P. , Bischof, John C , Finger, Erik B.

Mayo Clinic

No container title available | April 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.04.25.720819 | PMID 42094508 Get It

ABSTRACT Pancreatic islet transplantation can restore endogenous insulin production and offers a potential cure for diabetes, but its clinical impact has been limited by the inability to preserve large numbers of functional islets for timely use. Cryopreservation could provide an on-demand supply, yet conventional methods cause ice formation, cell injury, and loss of insulin secretion. We developed CryoMesh, a vitrification platform that combines a low-toxicity cryoprotectant with a thermally conductive, biocompatible mesh to enable ultra-rapid cooling and rewarming for ice-free cryopreservation. This approach supports long-term, clinical-scale preservation of both human pancreatic and stem cell–derived islets while maintaining viability, architecture, mitochondrial integrity, and glucose-responsive insulin secretion. Human islets preserved for up to one year restored normoglycemia in diabetic mice, with complete recovery of function and no increase in immunogenicity or loss of potency. The combination of high viability, recovery, and functional preservation at clinical scale has not been achieved previously. By decoupling islet isolation and manufacture from transplantation, CryoMesh enables extended quality, potency, and safety testing, cost-effective batch production, and global banking and distribution. These capabilities remove a major barrier to curative cell therapy for diabetes and establish a generalizable strategy for preserving complex multicellular therapeutics. One Sentence Summary A clinical scale vitrification platform enables long-term banking of human pancreatic and stem cell–derived islets for transplantation.
Chromosome-arm-specific telomere length governs dual modes of structural genome evolution in IDH-mutant astrocytoma
Jehangir, Maryam , Drucker, Kristen , Keskus, Ayse G. , Ranallo-Benavidez, T R, Benamozig, Orléna , Kollmeyer, Thomas , Giannini, Caterina , Kipp, Benjamin R. , Murphy, Stephen James, Bridgeman, Amber R. , Walsh, Jesse R. , Majumdar, Ramanath, Lachance, Daniel H , Eckel‐Passow, Jeanette E. , Jenkins, RB , Kollmeyer, Thomas M. , Ranallo-Benavidez, T. Rhyker , Drucker, Kristen L , Keskus, Ayse , Ranallo-Benavidez, T Rhyker , Giannini, Caterina , Kipp, Benjamin , Bridgeman, Amber R , Walsh, Jesse R , Lachance, Daniel , Eckel-Passow, Jeanette E , Shoshani, Ofer , Kolmogorov, Mikhail , Barthel, Floris P , Jehangir, Maryam , Burns, Terry C. , Jenkins, Robert B.

Mayo Clinic

No container title available | April 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.04.22.720226 | PMID 42079062 Get It

ABSTRACT IDH-mutant astrocytomas maintain telomeres through the alternative lengthening of telomeres (ALT) pathway, producing extreme inter-arm telomere length heterogeneity, yet how this heterogeneity shapes structural genome evolution remains unknown. Using Oxford Nanopore long-read sequencing of 20 IDH-mutant astrocytomas, we profiled structural variants (SVs), copy number variants, extrachromosomal DNA (ecDNA) and measured allele-specific telomere lengths from individual long reads. We identified pervasive complex rearrangements, including chromothripsis and foldback events consistent with breakage-fusion-bridge cycles, and widespread ecDNAs. SV breakpoints were enriched at telomeric and centromeric regions regardless of local telomere length, revealing constitutive structural fragility. Arm-level telomere length analysis uncovered a dual-mode model: arms with short telomeres preferentially harbored breakage-associated events, while arms with long ALT-maintained telomeres were enriched for ecDNA and amplification-associated events. These findings identify chromosome-arm-specific telomere length as a determinant of structural genome evolution in ALT-driven tumors.
Standardized Perioperative Protocols Are Associated With Reduced Length of Stay and Readmission in Cushing Disease: Results From the Multicenter RAPID Study
Suryadevara, Carter M. , Salcedo-Sifuentes, Jorge E., Little, Andrew S., Yuen, Kevin C. J., Mendoza, Michelle Magana, Gardner, Paul, Zenonos, Georgios, Silverstein, Julie M., Kim, Albert H., Evans, James J., Barkhoudarian, Garni, Fernandez-Miranda, Juan C., Couldwell, William T., Rennert, Robert C., Kim, Won, Kshettry, Varun R., Wu, Kyle, BENJAMIN, CAROLINA, Zada, Gabriel, Gompel, Jamie Van, Catalino, Michael P., Karsy, Michael, Rosenberg, Yaakov, Mamelak, Adam N, Agrawal, Nidhi , Pacione, Donato , Karsy, Michael , Van Gompel, Jamie, Karsy, Michael , Salcedo-Sifuentes, Jorge E. , Little, Andrew S. , Yuen, Kevin C.J. , Zenonos, Georgios A, Silverstein, Julie , Kim, Albert H , Evans, James J., Barkhoudarian, Garni , Fernandez‐Miranda, Juan C. , Couldwell, William T. , Rennert, Robert C , Kshettry, Varun R. , Zada, Gabriel , Chicoine, Michael , Gompel, Jamie J. Van , Catalino, Michael Paul, Agrawal, Nidhi

Mayo Clinic

Neurosurgery | April 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1227/neu.0000000000003992 | PMID 42012163 Get It

BACKGROUND AND OBJECTIVES: Perioperative protocols facilitate earlier discharge without compromising safety in nonfunctioning pituitary adenomas, but no large multicenter studies in the United States have investigated protocols regarding Cushing disease (CD). We sought to characterize perioperative protocols and how their implementation influences clinical outcomes in patients with CD. METHODS: A retrospective analysis was conducted using data from the Registry of Adenomas of the Pituitary and Related Disorders consortium comprising 13 US academic pituitary centers. Institutions were surveyed regarding perioperative procedures for patients undergoing transsphenoidal tumor resection for CD. The impacts of institutional procedures and approaches to implementation on length of stay (LOS) and unplanned 90-day readmission were evaluated. RESULTS: Thirteen institutions contributed survey responses and clinical data for a total of 832 patients meeting inclusion criteria. Ten (76.9%) institutions reported having a postoperative protocol, 9 (69.2%) used a formal document to outline their protocol, and 3 (23.1%) had protocols implemented into hospital policy. Mean LOS was significantly reduced in centers with an established protocol (3.14 vs 3.42 days, P = .032), and more so with a formal document (3.10 vs 3.48 days, P = .001) or hospital policy (2.72 vs 3.36 days, P < .001). Patients treated after protocol implementation experienced shorter LOS ( P < .001). Other factors associated with reduced LOS were presence of a separate CD pathway, intraoperative checklist specific to pituitary surgery, non-narcotic pain regimen, Foley removal order, dedicated outpatient advanced practice provider follow-up, and target discharge date ≤2 days. Intraoperative checklist ( P = .045), non-narcotic pain regimen ( P = .048), nasal packing ( P = .005), and 1-day target discharge date ( P = .032) were important factors against readmission. Compared with microscopic surgery, endoscopic surgery was associated with shorter LOS but increased readmission odds. CONCLUSION: This is the first multicenter study to illustrate that implementation of perioperative protocols is associated with a reduction in LOS and readmission risk in patients with CD.
Clinical and Radiometabolic Correlatives of ddPCR Liquid Biopsy for BRAF V600 Mutated Melanoma
Bilgin, Gokce Belge , Nikanpour, Yalda , Kipp, Benjamin R. , Zahrieh, David M. , Block, Matthew S. , Stoff, Ronen , Geiersbach, Katherine B. , Johnson, Geoffrey B. , Markovic, Svetomir N.

Mayo Clinic

International Journal of Cancer | April 21, 2026 | Volume: 159 | Issue: 4 | Pages: 1068-1078

10.1002/ijc.70514 | PMID 42011804 Get It

ABSTRACT Circulating tumor DNA (ctDNA) as a liquid biopsy is an emerging tool used for diagnosis and disease monitoring, yet not all tumors shed DNA equally, thus currently limiting the clinical applicability of this tool. Our institution has developed and validated a droplet digital Polymerase Chain Reaction (ddPCR) ctDNA test for BRAF V600 mutation. We collected data on all BRAF mutated melanoma patients tested with the ddPCR BRAF assay at our institution over the years 2018–2024 and correlated the test results with clinical and radiological baseline parameters, with a focus on Positron Emission Tomography‐Computed Tomography (PET‐CT) data, incorporating both location of lesions and volume of disease. Linear and logistic regression modelling was used to assess possible associations between the baseline parameters and the ctDNA results. We identified 71 BRAF mutated melanoma patients, of which 65 had active disease on imaging studies and 43 had PET‐CT data available for analysis. Multivariate modelling has shown that patients were more likely to have a positive ctDNA result if they had elevated serum lactate dehydrogenase (LDH) (OR = 9.9), had a higher number of lesions on imaging studies (> 10 lesions: OR = 11.3), and if they were younger than 65 (OR = 11.8), with an AUC of 0.84. The PET‐CT calculated total metabolic tumor volume correlated with the quantitative ctDNA result with a Pearson r factor of 0.49. In conclusion, ctDNA ddPCR BRAF testing is easily obtained and might be especially beneficial for patients diagnosed with a clinically aggressive disease, based on elevated LDH, higher PET‐CT metabolic tumor volume, and younger age.
NECROTIZING CELLULITIS DUE TO APOPHYSOMYCES ELEGANS AT A PATCH TEST SITE: 4
LeSueur, Benjamin W., Warschaw, Karen E., Fredrikson, Lorna J.

Mayo Clinic

American Journal of Contact Dermatitis | April 17, 2026 | Volume: 13 | Issue: 2 | Pages: 89-89

10.1053/ajcd.2002.3083 Get It

A Collaborative Initiative to Improve Anaphylaxis Management in Utah Schools
Witt, Bryan , Wright, Benjamin L. , Witt, Bryan S, Wright, Benjamin L

Mayo Clinic

Pediatrics | April 15, 2026 | Volume: 157 | Issue: 5 | Pages: No page available

10.1542/peds.2025-073978 | PMID 41980724 Get It

Food allergies are a significant public health concern in the United States. Fatality from food-induced anaphylaxis is associated with delayed administration of epinephrine. Utah children were at increased risk for school-related anaphylaxis due to a lack of school nurses, adequately trained staff, and a standardized approach to food allergy emergency management. In collaboration with the Utah School Nurses Association, the Utah Food Allergy Network, and the Utah Department of Health & Human Services, among other contributors, we aimed to accomplish the following goals: (1) develop and implement a web-based curriculum to train school staff to recognize and respond to anaphylaxis in school settings; (2) educate school officials on existing legal protections for layperson first responders; and (3) facilitate acquisition of unassigned epinephrine for use in schools through existing charitable pharmaceutical programs. From 2012 to 2023, our training program was completed 5759 times by individuals representing 421 Utah schools. The course was most frequently completed by teachers (n = 3006, 52.2%), office staff (n = 1480, 25.7%), and principals (n = 276, 4.8%). Since 2015, we have maintained an average year-to-year retention rate of greater than 68%. We observed a 245% increase in the number of schools with unassigned epinephrine. Due to this intervention, many Utah schools now prepare employees to administer epinephrine in the case of anaphylactic emergencies. Although school nurses play a significant role, their coverage is inadequate to meet the needs of all students at risk for anaphylaxis. Training volunteers to recognize and respond to anaphylaxis in school settings is needed to reduce delays in treatment and improve outcomes.